A Prospective Analysis To Assess The Potential Use Of ECGio In Clinical Practice
ConditionAI-algorithm Usage
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorHeart Input Output Inc
About this trial
The goal of this observational study is to learn if an ai-assistive algorithm would be useful in patients who are under suspicion of coronary disease. The main question it aims to answer:
What proportion of patients would clinicians see fit to order an ai-assistive algorithm if available for clinical use?
Participants will be asked to use clinical judgement as to whether a patient fits a predetermined criteria for use and select them for ai-assistive analysis.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
Patients with medical records stored in a digitized format.
Presenting between February 1 2026 and October 31 2026.
Hypertension
Disqualifiers
Patients with acute coronary syndrome (ACS).
Patient with prior Coronary Artery Bypass Grafting (CABG)
Patients whose ECG tracing has extreme noise or artifact to the extent that it would be recommended to redo the tracing.
Age ≥ 90 years.
Trial design
Treatments tested in this trial
- AI-Assistive Algorithm
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov